We further examined the functional impact of GAL-3 or HLA-DP/DQ/DR blockade on the specific proliferation and anti-tumor activities of MM-specific CD8+ CTL against MM cells in an HLA-A2-specific manner. This evidence concerns the gene CD8A and Miyoshi myopathy.